Literature DB >> 24306365

Changes in vitamin D and matrix metalloproteinase-9 in submariners during a submerged patrol.

A Baker1, C L Wood, A M Wood, P Timms, A J Allsopp.   

Abstract

OBJECTIVES: To quantify changes in vitamin D and matrix metalloproteinase-9 (MMP9) in submariners over a single long patrol and compare the data to a group of non-deploying servicemen from their base port.
METHODS: A prospective time-series analysis was performed. Blood samples were taken from 49 submariners deploying on patrol and 43 shore-side controls from the base port (naval officers from base or non-deploying submariners), following a winter ashore at latitude 56° north. Samples were drawn immediately before the submarine sailed, in January, and again in the final week of patrol 85 days later. Paired pre-patrol and late samples from each individual were assayed together and changes in vitamin D and MMP9 were assessed.
RESULTS: Mean pre-patrol vitamin D concentrations were 58 and 49 nmol/L for the controls and submariners, respectively. Mean vitamin D concentrations increased in controls as expected (mean increase 12.6 nmol/L), but not in the submariners (mean decrease 1.6 nmol/L). MMP9 levels were significantly higher in submariners pre-patrol, and increased significantly during the patrol. There was a significant inverse correlation between MMP9 and vitamin D levels (r=-0.41, p=0.01).
CONCLUSIONS: This is the first study to quantify vitamin D and MMP levels in submariners. Circulating vitamin D concentrations on board were insufficient to prevent a rise in MMP. This has potential for adverse health effects and requires further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306365     DOI: 10.1136/oemed-2013-101793

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  1 in total

1.  Matrix metalloproteinase-10 and microvascular complications of type 1 diabetes: might vitamin D status be relevant?

Authors:  Barbara J Boucher
Journal:  Diabetologia       Date:  2014-02-16       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.